InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001960048-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-11 2026-03-11 PCVX Cowan Elvia SVP, CAO, Fin S - Sale+OE $58.59 -2,500 30.9K -7% -$146.5K
D 2026-03-11 2026-03-11 PCVX Cowan Elvia SVP, CAO, Fin M - OptEx $25.92 +2,500 33.4K +8% +$64.8K
D 2026-03-11 2026-03-09 PCVX Cowan Elvia SVP, CAO, Fin F - Tax $59.32 -495 30.9K -2% -$29.4K
D 2026-03-11 2026-03-11 PCVX Cowan Elvia SVP, CAO, Fin M - OptEx $0.00 -2,500 96.1K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-11 S D 2,500 $58.59 30,867 D — —
2 Common Common Stock 2026-03-11 M A 2,500 $25.92 33,367 D — —
3 Common Common Stock 2026-03-09 F D 495 $59.32 30,867 D — — (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person.
4 Derivative Stock Option (right to buy) 2026-03-11 M D 2,500 $0.00 96,068 D $25.92 · — to 2032-08-08 2,500 Common Stock (F3) 1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.